Enveric Biosciences Files 8-K for Material Agreement
Ticker: ENVB · Form: 8-K · Filed: May 3, 2024 · CIK: 890821
| Field | Detail |
|---|---|
| Company | Enveric Biosciences, Inc. (ENVB) |
| Form Type | 8-K |
| Filed Date | May 3, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01, $0.94 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing, corporate-update
Related Tickers: ENVB
TL;DR
Enveric Bio (ENVB) signed a big deal, filing an 8-K today. Details to follow.
AI Summary
Enveric Biosciences, Inc. filed an 8-K on May 3, 2024, reporting the entry into a material definitive agreement. The filing also includes financial statements and exhibits. The company, formerly known as AMERI Holdings, Inc. and SPATIALIZER AUDIO LABORATORIES INC, is incorporated in Delaware and headquartered in Naples, Florida.
Why It Matters
This filing indicates a significant new agreement for Enveric Biosciences, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, and the specifics of this agreement are not detailed in the provided excerpt.
Key Players & Entities
- Enveric Biosciences, Inc. (company) — Registrant
- May 3, 2024 (date) — Date of Report
- AMERI Holdings, Inc. (company) — Former Company Name
- SPATIALIZER AUDIO LABORATORIES INC (company) — Former Company Name
- Delaware (jurisdiction) — State of Incorporation
- Naples, Florida (location) — Principal Executive Offices
FAQ
What is the nature of the material definitive agreement entered into by Enveric Biosciences?
The provided excerpt does not specify the details of the material definitive agreement, only that one was entered into.
When was the 8-K filing submitted?
The 8-K filing was submitted on May 3, 2024.
What were Enveric Biosciences' former company names?
Enveric Biosciences was formerly known as AMERI Holdings, Inc. and SPATIALIZER AUDIO LABORATORIES INC.
Where is Enveric Biosciences' principal executive office located?
Enveric Biosciences' principal executive office is located at 4851 Tamiami Trail N, Suite 200, Naples, FL 34103.
What is the SIC code for Enveric Biosciences?
The Standard Industrial Classification (SIC) code for Enveric Biosciences is 2834, Pharmaceutical Preparations.
Filing Stats: 841 words · 3 min read · ~3 pages · Grade level 10.6 · Accepted 2024-05-03 17:04:00
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share ENVB The Nasdaq Stock Mar
- $0.94 — conducted at a deemed offering price of $0.94 per share. The Purchase Agreements co
Filing Documents
- form8-k.htm (8-K) — 44KB
- ex5-1.htm (EX-5.1) — 26KB
- ex5-1_001.jpg (GRAPHIC) — 8KB
- ex5-1_002.jpg (GRAPHIC) — 11KB
- ex5-1_003.jpg (GRAPHIC) — 12KB
- ex5-1_004.jpg (GRAPHIC) — 4KB
- ex10-1.htm (EX-10.1) — 101KB
- 0001493152-24-017748.txt ( ) — 418KB
- envb-20240503.xsd (EX-101.SCH) — 3KB
- envb-20240503_lab.xml (EX-101.LAB) — 33KB
- envb-20240503_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 3, 2024 ENVERIC BIOSCIENCES, INC. By: /s/ Joseph Tucker Joseph Tucker, Ph.D. Chief Executive Officer